Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a progressive neurological disorder that affects older adult carriers, predominantly males, of premutation alleles (55 to 200 CGG repeats) of the fragile X (FMR1) gene. Principal features of FXTAS are intention tremor, ataxia, parkinsonism, cognitive decline, and peripheral neuropathy; ancillary features include, autonomic dysfunction, and psychiatric symptoms of anxiety, depression, and disinhibition. Although controlled trials have not been carried out in individuals with FXTAS, there is a significant amount of anecdotal information regarding various treatment modalities. Moreover, there exists a great deal of evidence regarding the efficacy of various medications for treatment of other disorders (eg, Alzheimer disease) that have substantial phenotypic overlap with FXTAS. The current review summarizes what is currently known regarding the symptomatic treatment, or potential for treatment, of FXTAS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 1×
“In addition, the use of selective serotonin reuptake inhibitors (SSRIs) to treat depression or anxiety can stimulate neurogenesis in the aging brain and may therefore be neuroprotective for later cognitive decline (Jacobs et al 2000; Santarelli et al 2003).”
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237
Unützer, J., Katon, W., Callahan, C. M., Williams, Jr., Hunkeler, E., Harpole, L., Hoffing, M., Della Penna, R. D., Noël, P. H., Lin, E. H. B., et al. (2002) · JAMA · doi:10.1001/jama.288.22.2836 · Cited by 2,405
Homocysteine and Cardiovascular Disease
Refsum, H., Ueland, P. M., Nygård, O., & Vollset, S. E. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.31 · Cited by 2,180 · cited 1×
“Hyperhomocys-teinemia is an independent risk factor for vascular disease, including cerebrovascular disease (Refsum et al 1998), and is associated with both an increased prevalence and incidence of AD and dementia (Clarke et al 1998; Miller et al 2002; Seshadri et al 2002; Haan et al 2007).”
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
Adult brain neurogenesis and psychiatry: a novel theory of depression
Jacobs, B. L., van Praag, H., & Gage, F. H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000712 · Cited by 964
Management of fibromyalgia syndrome
Goldenberg, D. L. (2004) · JAMA · doi:10.1001/jama.292.19.2388 · Cited by 850 · cited 2×
“The most effective pharmacologic treatments include antidepressant, anticonvulsant and/or muscle relaxant medications (Goldenberg et al 2004).”
Durga, J., van Boxtel, M. P., Schouten, E. G., Kok, F. J., Jolles, J., Katan, M. B., & Verhoef, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60109-3 · Cited by 758 · cited 1×
“Defi ciencies in B vitamins, particularly folate and vitamin B12, are common in elderly populations and have been associated with increased risk of cognitive impairment and dementia (Clarke et al 1998; Ramos et al 2005; de Lau et al 2007; Durga et al 2007).”
Rolland, Y., Pillard, F., Klapouszczak, A., Reynish, E., Thomas, D., Andrieu, S., Rivière, D., & Vellas, B. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01035.x · Cited by 661 · cited 2×
“Aerobic exercise has been found to modify cognition, such as executive functioning, and reduce symptoms of depression and behavioral problems in AD patient populations (Yu et al 2006; Rolland et al 2007).”
Zesiewicz, T. A., Elble, R., Louis, E. D., Hauser, R. A., Sullivan, K. L., Dewey, R. B., Ondo, W. G., Gronseth, G. S., & Weiner, W. J. (2005) · Neurology · doi:10.1212/01.wnl.0000163769.28552.cd · Cited by 371
FARZIN, F., PERRY, H., HESSL, D., LOESCH, D., COHEN, J., BACALMAN, S., GANE, L., TASSONE, F., HAGERMAN, P., & HAGERMAN, R. (2006) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200604002-00012 · Cited by 325 · cited 2×
“The treatment of cognitive impairment in FXTAS is based on off-label application of dementia treatments conventionally used in Alzheimer’s disease ( Farlow and Cummings 2007 ).”
Self-citationExecutive dysfunction and the course of geriatric depression
Alexopoulos, G. S., Kiosses, D. N., Heo, M., Murphy, C. F., Shanmugham, B., & Gunning-Dixon, F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.024 · Cited by 317 · cited 1×
“Executive dysfunction increases the risk of poor response of geriatric depression to medications (Alexopoulos et al 2005).”
Dombrowski, C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.4.371 · Cited by 289 · cited 1×
“Premutation alleles of the FMR1 gene are relatively common in the general population, carried by ~1 in 130–250 females and ~1 in 500–800 males (Rousseau et al 1995; Pesso et al 2000; Dombrowski et al 2002; Beckett et al submitted).”
Role of S-adenosyl-l-methionine in the treatment of depression: a review of the evidence,,,
Mischoulon, D., & Fava, M. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.1158s · Cited by 285 · cited 1×
“Of note is that both folate and vitamin B12 defi ciencies have been associated with depression (Alpert and Fava 1997), Powered by TCPDF (www.tcpdf.org) and oral supplements of SAM have been shown to alleviate depressive symptoms (Mischoulon and Fava 2002).”
Miyai, I., Fujimoto, Y., Yamamoto, H., Ueda, Y., Saito, T., Nozaki, S., & Kang, J. (2002) · Archives of Physical Medicine and Rehabilitation · doi:10.1053/apmr.2002.34603 · Cited by 284 · cited 1×
“Lasting improvements in overground walking speed, stride length, cadence, and fall reduction have been seen with physical therapy and particularly with body-weight-supported treadmill training (Miyai et al 2002; Pohl et al 2003; Protas et al 2005).”
Ellis, T., de Goede, C. J., Feldman, R. G., Wolters, E. C., Kwakkel, G., & Wagenaar, R. C. (2005) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2004.08.008 · Cited by 242 · cited 1×
“In addition to pharmacological treatment, physical therapy can be helpful for improving strength and gait in treatment of patients with ataxia and parkinsonism, particularly as these patients continue to age (Ellis et al 2005; Cao et al 2007).”
Jankovic, J., Schwartz, K., Clemence, W., Aswad, A., & Mordaunt, J. (1996) · Movement Disorders · doi:10.1002/mds.870110306 · Cited by 235 · cited 1×
“Placebo controlled trials of BTX in essential tremor have shown that in some cases there is signifi cant reduction of tremor amplitude, but only mild functional improvement associated with problematic limb weakness (Jankovic et al 1996; Brin et al 2001; Cordivari et al 2004).”
Ramos, M. I., Allen, L. H., Mungas, D. M., Jagust, W. J., Haan, M. N., Green, R., & Miller, J. W. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.6.1346 · Cited by 188
Self-citationBacalman, S., Farzin, F., Bourgeois, J. A., Cogswell, J., Goodlin-Jones, B. L., Gane, L. W., Grigsby, J., Leehey, M. A., Tassone, F., & Hagerman, R. J. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0112 · Cited by 175 · cited 3×
“…o r pe r s ona l u s e on l y . a subgroup of premutation carriers may have psychiatric problems even in childhood or adolescence, with features that can include ADHD, obsessive/compulsive thinking, anxiety disorders, or social diffi culties (Cornish et al 2005; Farzin et al 2006; Hessl et al 2006).”
Self-citationThe emerging fragile X premutation phenotype: Evidence from the domain of social cognition
Cornish, K., Kogan, C., Turk, J., Manly, T., James, N., Mills, A., & Dalton, A. (2005) · Brain and Cognition · doi:10.1016/j.bandc.2004.08.020 · Cited by 148
Efficacy of primidone in essential tremor
Koller, W. C., & Royse, V. L. (1986) · Neurology · doi:10.1212/wnl.36.1.121 · Cited by 138
Cherrier, M. M., Craft, S., & Matsumoto, A. H. (2003) · Journal of Andrology · doi:10.1002/j.1939-4640.2003.tb02708.x · Cited by 117
Effectiveness of Massage Therapy for Chronic, Non‐Malignant Pain: A Review
Tsao, J. C. I. (2007) · Evidence-Based Complementary and Alternative Medicine · doi:10.1093/ecam/nel109 · Cited by 106 · cited 4×
“Cognitive changes in patients with FXTAS include executive function defi cits and memory problems, which may be present at the time the individual is diagnosed with tremor and/or ataxia (Grigsby et al 2006, 2007).”
InfluentialPyridostigmine in the Treatment of Orthostatic Intolerance
Gales, B. J., & Gales, M. A. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h458 · Cited by 39 · cited 1×
“Pyridostigmine can also be used for orthostatic hypotension (Gales and Gales 2007), which is also common in FXTAS.”
Quantitative comparison of barbiturates in essential hand and head tremor
Sasso, E., Perucca, E., Fava, R., & Calzetti, S. (1991) · Movement Disorders · doi:10.1002/mds.870060112 · Cited by 31
Cited by
Advances in the Treatment of Fragile X Syndrome
Hagerman, R. J., Berry-Kravis, E., Kaufmann, W. E., Ono, M. Y., Tartaglia, N., Lachiewicz, A., Kronk, R., Delahunty, C., Hessl, D., Visootsak, J., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-0317 · Cited by 596
Self-citationHagerman, R., & Hagerman, P. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70125-x · Cited by 313
Self-citationFragile X-associated tremor/ataxia syndrome — features, mechanisms and management
Hagerman, R. J., & Hagerman, P. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.82 · Cited by 290
Self-citationFMR1 premutation and full mutation molecular mechanisms related to autism
Hagerman, R., Au, J., & Hagerman, P. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9084-5 · Cited by 85
Self-citationCareaga, M., Noyon, T., Basuta, K., Van de Water, J., Tassone, F., Hagerman, R. J., & Ashwood, P. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-110 · Cited by 20
Self-citation
Metadata
- Authors
- Hagerman, R.
- Venue
- Clinical Interventions in Aging
- Publisher
- Informa UK Limited
- Published
- 2008-06
- Volume
- Volume 3
- Issue
- 2
- Pages
- 251-262
- ISSN
- 1176-9092 (ISSN-L)
- 1178-1998
- OpenAlex
- W2115628281
- Cited by
- 131
- References
- 26
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.